158. 結節性硬化症 Tuberous sclerosis Clinical trials / Disease details

臨床試験数 : 112 / 薬物数 : 71 - (DrugBank : 19) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 118

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04987463 (ClinicalTrials.gov)	May 7, 2021	28/5/2021	Efficacy and Safety of Rapamycin Versus Vigabatrinin the Prevention of Tuberous Sclerosis Complex Sy ...	Randomized, Placebo-controlled, Double-blind and Double-dummy Clinical Trial Comparing the Safety, T ...	Tuberous Sclerosis Complex	Drug: Vigabatrin;Drug: Rapamycin;Drug: Placebo	Katarzyna Kotulska	NULL	Recruiting	4 Weeks	16 Weeks	All	60	Phase 2/Phase 3	Poland
2	NCT02849457 (ClinicalTrials.gov)	December 2016	13/7/2016	Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex	Preventing Epilepsy Using VigabatrinIn Infants With Tuberous Sclerosis Complex (PREVeNT Trial) A Ran ...	Tuberous Sclerosis Complex	Drug: Vigabatrin;Drug: Placebo	Martina Bebin	National Institute of Neurological Disorders and Stroke (NINDS)	Active, not recruiting	N/A	6 Months	All	84	Phase 2	United States
3	EUCTR2013-005528-40-BE (EUCTR)	11/12/2014	17/11/2014	Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a ge ...	Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a ge ...	epilepsy in tuberous sclerosis complex (TSC);Therapeutic area: Diseases [C] - Nervous System Disease ...	Trade Name: vigabatrin (sabril) Product Name: vigabatrin INN or Proposed INN: VIGABATRIN	Vrije Universiteit Brussel	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100		Belgium;Netherlands
4	EUCTR2013-005528-40-NL (EUCTR)	05/12/2014	14/07/2014	Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a ge ...	Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a ge ...	Epilepsy in tuberous sclerosis complex (TSC) MedDRA version: 17.0;Level: LLT;Classification code 100 ...	Trade Name: Vigabatrin (Sabril) Product Name: vigabatrin	The Children's Memorial Health Institute	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100		Belgium;Netherlands
5	NCT01266291 (ClinicalTrials.gov)	August 2010	22/12/2010	Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients	Sabril for Treatment of Adult Refractory Partial Seizures Symptomatic of Tuberous Sclerosis: An Open ...	Complex Partial Seizures	Drug: vigabatrin	University of Pennsylvania	H. Lundbeck A/S	Terminated	18 Years	N/A	All	1	Phase 4	United States
6	EUCTR2020-003231-19-PL (EUCTR)		09/10/2020	Comparison of the efficacy and safety of rapamycin versus vigabatrinin the prevention of Tuberous Sc ...	Randomized, placebo-controlled, double-blind and double-dummy clinical trial comparing the safety, t ...	Tuberous Sclerosis ComplexEpilepsyTumors associated with Tuberous Sclerosis Complex;Therapeutic area ...	Trade Name: SABRIL 500 mg, granules for oral solution Trade Name: RAPAMUNE 1 mg/ml oral solution	The Children's Memorial Health Institute	NULL	NA			Female: yes Male: yes	60	Phase 2;Phase 3	Poland

First Previous1Next Last